StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.14−0.10 (-4.46%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Biodexa Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2017 it was 674.6%, against 472.9% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2017Dec 31, 2017674.6%+201.8
FY2016Dec 31, 2016472.9%+378.0
FY2015Dec 31, 201594.9%–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?